Advances in Multiple Sclerosis and Experimental Demyelinating Diseases by Moses
162,37 €
Benign Multiple Sclerosis: A Distinct Clinical Entity with Therapeutic Implications. - Pathological Heterogeneity of Idiopathic Central Nervous System Inflammatory Demyelinating Disorders. - Multiple Sclerosis Genetics.
Jetzt bei Ebay: